Biocon Biologics

📍 Bengaluru, India🗓 Founded 1978👥 4,542 employees💰 Last funded Nov 2020
Biotechnology Research🌐 bioconbiologics.com
Website LinkedIn
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1978
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Biocon Biologics?
Biocon Biologics has 1 investors on record on gritt.io.
When did Biocon Biologics last raise funding?
The most recent investment in Biocon Biologics recorded on gritt.io was in November 2020.
When was Biocon Biologics founded?
Biocon Biologics was founded in 1978.
What industry is Biocon Biologics in?
Biocon Biologics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biocon Biologics based?
Biocon Biologics is headquartered in Bengaluru, India.